P2.205 A phase I/II clinical trial to evaluate the safety and efflcacy of ProSavin®, a gene therapy approach for Parkinson's disease - Jarraya, B.; Lepetit, H.; Ralph, S.; Boulet, S.; Jan, C.; Bonvento, G.; Miskin, J.; Gurruchaga, J.-M.; Vinti, M.; Fenelon, G.; Brugière, P.; Kingsman, S.; et al. (Parkinsonism & Related Disorders, 2009)